Form 8-K - Current report:
SEC Accession No. 0000950170-24-110435
Filing Date
2024-09-30
Accepted
2024-09-30 17:19:43
Documents
13
Period of Report
2024-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pkbo-20240924.htm   iXBRL 8-K 45102
2 EX-10.1 pkbo-ex10_1.htm EX-10.1 35760
3 EX-10.2 pkbo-ex10_2.htm EX-10.2 37221
  Complete submission text file 0000950170-24-110435.txt   253521

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pkbo-20240924.xsd EX-101.SCH 26948
16 EXTRACTED XBRL INSTANCE DOCUMENT pkbo-20240924_htm.xml XML 5093
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

EIN.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 241340468
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)